Skip to main content

Advertisement

SpringerLink
Log in

The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report

  • Case Report
  • Published:
Archives of Women's Mental Health Aims and scope Submit manuscript

Abstract

We report on a 61-year-old postmenopausal female with schizophrenia included in a raloxifene vs. placebo clinical trial and monitored during a 12-month period including a 3-month withdrawal period (6–9 months) without treatment. The patient was treated with raloxifene 60 mg/day adjuvant to antipsychotic medication for 6 months, medication was then withdrawn for 3 months and was reintroduced due to a worsening of symptoms. We assessed the patient with PANSS and other neuropsychological tests. The patient improved in psychopathology and cognitive level in some aspects related to executive functions. During 3 months without the drug, the patient’s condition deteriorated. When the drug was reintroduced, improvements were again observed. Raloxifene may be useful as an adjuvant treatment for psychopathological symptoms and some cognitive aspects in women with chronic schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Benedet MJ, Alexandre MA (1998) Test de aprendizaje verbal España-Complutense (TAVEC). TEA, Madrid

    Google Scholar 

  • Huerta-Ramos E, Iniesta R, Ochoa S, Cobo J, Miquel E, Roca M, Serrano-Blanco A, Teba F, Usall J (2014) Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. Eur Neuropsychopharmacol 24:223–231

    Article  CAS  PubMed  Google Scholar 

  • Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276

    Article  CAS  PubMed  Google Scholar 

  • Kianimehr G, Fatehi F, Hashempoor S, Khodaei-Ardakani MR, Rezaei F, Nazari A, Kashani L, Akhondzadeh S (2014) Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo-controlled trial. Daru 22:55

    Article  PubMed Central  PubMed  Google Scholar 

  • Ko SS, Jordan VC (2011) Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene. Expert Opin Pharmacother 12:657–674

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kulkarni J, Gurvich C, Lee SJ, Gilbert H, Gavrilidis E, de Castella A, Berk M, Dodd S, Fitzgerald PB, Davis SR (2010) Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology 35:1142–1147

  • Landry M, Di Paolo T (2003) Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Brain Res Mol Brain Res 112:82–89

    Article  CAS  PubMed  Google Scholar 

  • Landry M, Lévesque D, Di Paolo T (2002) Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain. Neuroendocrinology 76:214–222

    Article  CAS  PubMed  Google Scholar 

  • Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and across-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 334:1–100

    Article  CAS  Google Scholar 

  • Reitan R, Wolfson D (1995) Category test and trail making test as measures of frontal lobe functions. Clin Neuropsychol 9:50–56

    Article  Google Scholar 

  • Seisdedos N, Corral S, Cordero A, de la Cruz MV, Hernández MV, Pereña J (1999) WAIS III. Manual Técnico. TEA, Madrid

    Google Scholar 

  • Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commen- tary, 3rd edn. Oxford University Press, New York

    Google Scholar 

  • Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643–662

    Article  Google Scholar 

  • Usall J, Huerta-Ramos E, Iniesta R, Cobo J, Araya S, Roca M, Serrano-Blanco A, Teba F, Ochoa S (2011) Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 72:1552–1557

    Article  CAS  PubMed  Google Scholar 

  • Wong J, Seeman MV, Shapiro H (2003) Case report: raloxifene in postmenopausal women with psychosis: preliminary findings. Am J Geriatr Psychiatry 11:697–698

    PubMed  Google Scholar 

  • Zec RF, Trivedi MA (2002) The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev 12:65–109

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parc Sanitari Sant Joan de Déu, C/Antoni Pujadas, 42, Sant Boi de Llobregat, 08830, Barcelona, Spain

    Elena Huerta-Ramos, Susana Ochoa, Mercedes Roca, Eva Miquel & Judith Usall

  2. Department of Psychiatry and Legal Medicine, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain

    Elena Huerta-Ramos

  3. Instituto de Salud Carlos III, Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain

    Elena Huerta-Ramos, Susana Ochoa, Mercedes Roca & Judith Usall

Authors
  1. Elena Huerta-Ramos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susana Ochoa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mercedes Roca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eva Miquel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Judith Usall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Huerta-Ramos.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huerta-Ramos, E., Ochoa, S., Roca, M. et al. The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report. Arch Womens Ment Health 18, 259–261 (2015). https://doi.org/10.1007/s00737-015-0500-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00737-015-0500-9

Keywords

Search

Navigation